Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2002 4
2003 10
2004 10
2005 9
2006 8
2007 9
2008 3
2009 5
2010 1
2011 2
2012 2
2013 6
2014 6
2015 9
2016 6
2017 4
2018 11
2019 8
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Results by year
Filters applied: . Clear all
Page 1
PD-1/PD-L1 inhibitors in haematological malignancies: update 2017.
Jelinek T, Mihalyova J, Kascak M, Duras J, Hajek R. Jelinek T, et al. Immunology. 2017 Nov;152(3):357-371. doi: 10.1111/imm.12788. Epub 2017 Aug 4. Immunology. 2017. PMID: 28685821 Free PMC article. Review.
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.
Jelinek T, Paiva B, Hajek R. Jelinek T, et al. Front Immunol. 2018 Nov 16;9:2431. doi: 10.3389/fimmu.2018.02431. eCollection 2018. Front Immunol. 2018. PMID: 30505301 Free PMC article. Review.
Extramedullary disease in multiple myeloma - controversies and future directions.
Sevcikova S, Minarik J, Stork M, Jelinek T, Pour L, Hajek R. Sevcikova S, et al. Among authors: Jelinek T. Blood Rev. 2019 Jul;36:32-39. doi: 10.1016/j.blre.2019.04.002. Epub 2019 Apr 13. Blood Rev. 2019. PMID: 31005420 Free article. Review.
The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.
Moreno L, Perez C, Zabaleta A, Manrique I, Alignani D, Ajona D, Blanco L, Lasa M, Maiso P, Rodriguez I, Garate S, Jelinek T, Segura V, Moreno C, Merino J, Rodriguez-Otero P, Panizo C, Prosper F, San-Miguel JF, Paiva B. Moreno L, et al. Among authors: Jelinek T. Clin Cancer Res. 2019 May 15;25(10):3176-3187. doi: 10.1158/1078-0432.CCR-18-1597. Epub 2019 Jan 28. Clin Cancer Res. 2019. PMID: 30692097 Free article.
Venetoclax: A new wave in hematooncology.
Mihalyova J, Jelinek T, Growkova K, Hrdinka M, Simicek M, Hajek R. Mihalyova J, et al. Among authors: Jelinek T. Exp Hematol. 2018 May;61:10-25. doi: 10.1016/j.exphem.2018.02.002. Epub 2018 Mar 2. Exp Hematol. 2018. PMID: 29477371 Review.
[Rabbies vaccination].
Jelinek T. Jelinek T. Ther Umsch. 2016;73(5):257-60. doi: 10.1024/0040-5930/a000789. Ther Umsch. 2016. PMID: 27268449 Review. German.
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
Schwameis M, Kündig T, Huber G, von Bidder L, Meinel L, Weisser R, Aberer E, Härter G, Weinke T, Jelinek T, Fätkenheuer G, Wollina U, Burchard GD, Aschoff R, Nischik R, Sattler G, Popp G, Lotte W, Wiechert D, Eder G, Maus O, Staubach-Renz P, Gräfe A, Geigenberger V, Naudts I, Sebastian M, Reider N, Weber R, Heckmann M, Reisinger EC, Klein G, Wantzen J, Jilma B. Schwameis M, et al. Among authors: Jelinek T. Lancet Infect Dis. 2017 Mar;17(3):322-329. doi: 10.1016/S1473-3099(16)30529-1. Epub 2016 Dec 20. Lancet Infect Dis. 2017. PMID: 28007428 Clinical Trial.
Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data.
Lingscheid T, Kurth F, Clerinx J, Marocco S, Trevino B, Schunk M, Muñoz J, Gjørup IE, Jelinek T, Develoux M, Fry G, Jänisch T, Schmid ML, Bouchaud O, Puente S, Zammarchi L, Mørch K, Björkman A, Siikamäki H, Neumayr A, Nielsen H, Hellgren U, Paul M, Calleri G, Kosina P, Myrvang B, Ramos JM, Just-Nübling G, Beltrame A, Saraiva da Cunha J, Kern P, Rochat L, Stich A, Pongratz P, Grobusch MP, Suttorp N, Witzenrath M, Hatz C, Zoller T; TropNet Schistosomiasis Investigator Group. Lingscheid T, et al. Among authors: Jelinek T. Am J Trop Med Hyg. 2017 Aug;97(2):567-574. doi: 10.4269/ajtmh.17-0034. Epub 2017 Jul 19. Am J Trop Med Hyg. 2017. PMID: 28722637 Free PMC article.
[What is verified for travel vaccinations?].
Jelinek T. Jelinek T. Internist (Berl). 2018 Dec;59(12):1255-1267. doi: 10.1007/s00108-018-0511-5. Internist (Berl). 2018. PMID: 30284598 Review. German.
114 results
Jump to page
Feedback